Web Desk. The world will have to be cautious about the supply of corona vaccines for the next six months as it will take time for a large part of the population to be vaccinated. This was stated by Dr. Somya Swami Nathan, Chief Scientist of the World Health Organization (WHO) in an interview.
We are moving towards the start of the end and we can see a ray of sunshine on the edge of the tunnel, however, we still have to go through the tunnel and therefore the next few months are vital,” he told CNBC.
He said the vaccine would initially protect very few people at high risk, while it could take months for it to reach the entire population. In some of the countries, the population may have to wait till up to the end of 2021 to reach the stage of resilience. Until then, we’ve to use caution, we’ve to require all the steps that may limit the unfold of the coronavirus,” he said.
We have to wait till up to the end of next year for the situation to get better. so that a better picture emerges, but I think the next few months can be tough,” said Sumia Swami Nathan. A new type of corona emerging in the UK. He also spoke about a new species recently discovered in the UK.
It’s uncommon as a result of its heaps of mutations and that is why it’s completely different from traditional varieties,” he said. The most worrying issue is that eight mutations occurred within the spike protein section,” he said.
Spike protein is the part of the virus that allows the virus to enter cells by binding to receptors S2 on the surface of human cells. However, he noted that the new type of disease does not appear to increase the severity of the disease.
The World Health Organization (WHO) said in a statement that the new strain of the virus could spread rapidly, but there was still insufficient evidence to determine whether the mutations were due to disease severity, antibody reaction, or vaccine. Is causing changes in its usefulness.
Sumia Swami Nathan said there was no reason to believe that vaccines would not work against it, as vaccines produce a broad immune response that could potentially be effective against this new strain.
If there is a need for any change in vaccines, it will be easily possible, but like most people at the moment, we think that the existing vaccines will work against it,” he added.